Lanzhou Foci Pharmaceutical Co Ltd (002644) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Lanzhou Foci Pharmaceutical Co Ltd (002644) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.62 Million ≈ $11.07 Million USD) by net assets (CN¥1.85 Billion ≈ $270.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Lanzhou Foci Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Lanzhou Foci Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Lanzhou Foci Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lanzhou Foci Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lanzhou Foci Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gan Yuan Foods Co Ltd SHE:002991	0.067x
CHC Resources Corp TW:9930	0.081x
Flying Technology Co Ltd SHG:603488	0.041x
Shanghai HIUV New Materials Co Ltd SHG:688680	0.069x
Hollyland China Electronics Technology Corp Ltd SHE:002729	0.036x
Tectonic Therapeutic, Inc. NASDAQ:TECX	-0.080x
Fineotex Chemical Limited NSE:FCL	0.021x
SGL Carbon SE XETRA:SGL	0.021x

Annual Cash Flow Conversion Efficiency for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 002644 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.81 Billion ≈ $265.59 Million	CN¥38.98 Million ≈ $5.70 Million	0.021x	-42.20%
2023-12-31	CN¥1.77 Billion ≈ $258.78 Million	CN¥65.71 Million ≈ $9.62 Million	0.037x	-10.97%
2022-12-31	CN¥1.73 Billion ≈ $253.73 Million	CN¥72.37 Million ≈ $10.59 Million	0.042x	+472.99%
2021-12-31	CN¥1.63 Billion ≈ $238.15 Million	CN¥11.85 Million ≈ $1.73 Million	0.007x	-81.62%
2020-12-31	CN¥1.59 Billion ≈ $232.24 Million	CN¥62.89 Million ≈ $9.20 Million	0.040x	+24.86%
2019-12-31	CN¥1.51 Billion ≈ $220.51 Million	CN¥47.82 Million ≈ $7.00 Million	0.032x	+24.68%
2018-12-31	CN¥1.44 Billion ≈ $210.78 Million	CN¥36.66 Million ≈ $5.36 Million	0.025x	-47.92%
2017-12-31	CN¥1.36 Billion ≈ $198.89 Million	CN¥66.42 Million ≈ $9.72 Million	0.049x	+10.85%
2016-12-31	CN¥1.29 Billion ≈ $188.85 Million	CN¥56.90 Million ≈ $8.33 Million	0.044x	-15.17%
2015-12-31	CN¥1.23 Billion ≈ $180.52 Million	CN¥64.11 Million ≈ $9.38 Million	0.052x	-59.24%
2014-12-31	CN¥735.22 Million ≈ $107.59 Million	CN¥93.75 Million ≈ $13.72 Million	0.128x	+956.24%
2013-12-31	CN¥703.37 Million ≈ $102.93 Million	CN¥-10.47 Million ≈ $-1.53 Million	-0.015x	+8.69%
2012-12-31	CN¥675.53 Million ≈ $98.85 Million	CN¥-11.02 Million ≈ $-1.61 Million	-0.016x	-535.65%
2011-12-31	CN¥648.08 Million ≈ $94.84 Million	CN¥2.43 Million ≈ $355.00K	0.004x	-97.82%
2010-12-31	CN¥326.46 Million ≈ $47.77 Million	CN¥56.18 Million ≈ $8.22 Million	0.172x	+1156.35%
2009-12-31	CN¥252.96 Million ≈ $37.02 Million	CN¥3.46 Million ≈ $507.01K	0.014x	+392.85%
2008-12-31	CN¥216.81 Million ≈ $31.73 Million	CN¥602.56K ≈ $88.17K	0.003x	-99.49%
2007-12-31	CN¥195.20 Million ≈ $28.56 Million	CN¥105.61 Million ≈ $15.45 Million	0.541x	--

About Lanzhou Foci Pharmaceutical Co Ltd

SHE:002644 China Drug Manufacturers - Specialty & Generic

Market Cap

$547.74 Million

CN¥3.74 Billion CNY

Market Cap Rank

#11902 Global

#3447 in China

Share Price

CN¥7.33

Change (1 day)

-2.40%

52-Week Range

CN¥7.33 - CN¥11.76

All Time High

CN¥18.02